Multi-luminance mobility testing after gene therapy in the context of retinal functional diagnostics
Graefe's Archive for Clinical and Experimental Ophthalmology · 2024
DOI: 10.1007/s00417-023-06237-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Graefe's Archive for Clinical and Experimental Ophthalmology, 2024. Verfasst von Ronja Jung und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Eye Hospital, Center for Ophthalmology, University of Tuebingen, Elfriede-Aulhorn-Str.7, Tübingen, Germany. ronja.jung@med.uni-tuebingen.d…. Hauptthemen laut MEDLINE: cis-trans-Isomerases, Leber Congenital Amaurosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Tübingen.
Themen: Mobilisation
Abstract (Originalsprache)
Background
Voretigene neparvovec (Luxturna®) is the first approved gene therapy for RPE65-linked Leber congenital amaurosis (LCA). Though individual effects are highly variable, most recipients report improved vision in everyday life. To describe such effects, visual navigation tests are now frequently used in clinical trials. However, it is still unclear how their results should be interpreted compared to conventional parameters of visual function.
Methods
Seven LCA patients underwent a multi-luminance visual navigation test (Ora-VNCTM) before and 3 months after receiving Luxturna gene therapy. Their performance was rated based on the luminance level at which they passed the course. Differences between the first and second test were correlated to changes in visual acuity, full-field stimulus thresholds, chromatic pupil campimetry, and dark-adapted perimetry.
Results
A few patients displayed notable improvements in conventional measures of visual function whereas patients with advanced retinal degeneration showed no relevant changes. Independent of these results, almost all participants improved in the visual navigation task by one or more levels. The improvement in the mobility test was best correlated to the change in full-field stimulus thresholds. Other measures of visual functions showed no clear correlation with visual navigation.
Discussion
In patients who passed the test’s more difficult levels, improved visual navigation can be attributed to the reactivation of rods. However, the performance of patients with low vision seemed to depend much more on confounding factors in the easier levels. In sum, such tests might only be meaningful for patients with better preserved visual functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Eye Hospital, Center for Ophthalmology, University of Tuebingen, Elfriede-Aulhorn-Str.7, Tübingen, Germany. ronja.jung@med.uni-tuebingen.de.
- University Eye Hospital, Center for Ophthalmology, University of Tuebingen, Elfriede-Aulhorn-Str.7, Tübingen, Germany.
- Center for Rare Eye Diseases, University of Tübingen, Tübingen, Germany.
- University Eye Hospital, Center for Ophthalmology, University of Tuebingen, Elfriede-Aulhorn-Str.7, Tübingen, Germany. Katarina.Stingl@med.uni-tuebingen.de.
- Center for Rare Eye Diseases, University of Tübingen, Tübingen, Germany. Katarina.Stingl@med.uni-tuebingen.de.
Förderung
- Universitätsklinikum Tübingen
Zitieren
APA
Jung, R., Kempf, M., Holocher, S., Kortüm, F. C., Stingl, K., & Stingl, K. (2024). Multi-luminance mobility testing after gene therapy in the context of retinal functional diagnostics. Graefe's Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-023-06237-4
Vancouver
Jung R, Kempf M, Holocher S, Kortüm FC, Stingl K, Stingl K. Multi-luminance mobility testing after gene therapy in the context of retinal functional diagnostics. Graefe's Archive for Clinical and Experimental Ophthalmology. 2024. doi:10.1007/s00417-023-06237-4
BibTeX
@article{Jung2024,
author = {Jung, Ronja and Kempf, Melanie and Holocher, Saskia and Kortüm, Friederike C and Stingl, Krunoslav and Stingl, Katarina},
title = {Multi-luminance mobility testing after gene therapy in the context of retinal functional diagnostics},
journal = {Graefe's Archive for Clinical and Experimental Ophthalmology},
year = {2024},
doi = {10.1007/s00417-023-06237-4}
}
EUVIMED